A Prospective Phase III Parallel, randomised controlled trial using double-bolus recombinant staphylokinase (THR-100) vs streptokinase in patients with acute myocardial infarction.

Trial Profile

A Prospective Phase III Parallel, randomised controlled trial using double-bolus recombinant staphylokinase (THR-100) vs streptokinase in patients with acute myocardial infarction.

Completed
Phase of Trial: Phase III

Latest Information Update: 24 Aug 2016

At a glance

  • Drugs THR 100 (Primary) ; Streptokinase
  • Indications Myocardial infarction
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 26 Sep 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 01 Mar 2011 Additional location identified (USA) and actual initiation date (Oct 2010) added as reported by ClinicalTrials.gov.
    • 01 Mar 2011 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health; NCT01305226).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top